ENVERIC BIOSCIENCES INC (ENVB)       6.6  -0.09 (-1.35%)

6.6  -0.09 (-1.35%)

US29405E2081 - Common Stock - Premarket: 6.62 +0.02 (+0.3%)

News Image
6 days ago - FinancialNewsMedia

Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study whether the active component of “magic” mushrooms can be used to treat depression. Researchers will explore whether the psychoactive effects are necessary to […]

News Image
6 days ago - Microsmallcap.com

Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression

/PRNewswire/ -- Toronto's Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study whether the active component of...

News Image
8 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday!

News Image
12 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday!

News Image
20 days ago - Enveric Biosciences, Inc.

Enveric Biosciences Appoints New Independent Directors

News Image
a month ago - Enveric Biosciences, Inc.

Enveric Biosciences Announces Reverse Stock Split

News Image
2 months ago - Enveric Biosciences

Enveric Biosciences to Participate in Upcoming Conferences in June 2022

/PRNewswire/ - Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation,...

News Image
3 months ago - Enveric Biosciences

Enveric Biosciences to Participate in the Microdose Psychedelic Capital Conference on May 26, 2022

/PRNewswire/ - Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation,...